title: Sulfonylurea receptor ligands modulate stretch-induced ANF secretion in rat atrial myocyte culture.
abstract: Stretch-induced atrial natriuretic factor (ANF) secretion was studied in cultures of neonate atrial appendage myocytes. Stretch, applied for 40 min by hypotonic swelling, increased the mean area of 44 individually imaged myocytes by 4.8-8.8% (P < 0.0001) at 6 min and by 2.3-6.2% (P < 0.05) at 35 min. Stretch increased immunoreactive ANF release by 42% (P < 0.05) from a baseline of 315 pg/ml. The ATP-sensitive K(+) (K(ATP))-channel blocker tolbutamide (100 micromol/l) increased the stretch-stimulated release to 84% (P < 0.01) over baseline, whereas lower concentrations (1, 10, and 30 micromol/l) had no stimulatory effect. The K(ATP)-channel opener diazoxide (0.1, 1, 10, 30, and 100 micromol/l) inhibited stretch- plus tolbutamide-stimulated ANF release in a concentration-dependent manner, with IC(50) = 2.2 micromol/l, although 100 micromol/l diazoxide did not reduce the increase in mean cell area. The stretch-stimulated K(ATP) current, monitored in 82 whole cell recordings with sulfonylurea receptor (SUR) ligands, was inversely correlated with the stretch-induced ANF release (r(2) = 0.79, P < 0. 0001). In the absence of stretch, the K(ATP) current had no relationship with baseline ANF release, and baseline ANF release was not affected by the K(ATP)-channel modulators. The results show that SUR ligands that open K(ATP) channels inhibit stretch-induced ANF release in atrial myocytes, in correlation with the stretch-activated K(ATP) current. The subcellular site of action of the SUR ligands-plasmalemma or intracellular organelles-remains to be determined.
authors.affiliation: Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville 22903, USA.
authors.forename: J H
authors.initials: JH
authors.lastname: Jiao
authors.forename: P
authors.initials: P
authors.lastname: Baumann
authors.forename: A
authors.initials: A
authors.lastname: Baron
authors.forename: A
authors.initials: A
authors.lastname: Roatti
authors.forename: R A
authors.initials: RA
authors.lastname: Pence
authors.forename: A J
authors.initials: AJ
authors.lastname: Baertschi
mesh_terms: D018528:ATP-Binding Cassette Transporters; D000255:Adenosine Triphosphate / Q000502:physiology; D000818:Animals; D009320:Atrial Natriuretic Factor / Q000378:metabolism*; D002478:Cells, Cultured; D003847:Deoxyglucose / Q000494:pharmacology; D003981:Diazoxide / Q000494:pharmacology; D004553:Electric Conductivity; D006325:Heart Atria; D008024:Ligands; D009206:Myocardium / Q000166:cytology / Q000378:metabolism*; D010812:Physical Stimulation; D026902:Potassium Channel Blockers; D015221:Potassium Channels / Q000187:drug effects / Q000378:metabolism* / Q000502:physiology; D024661:Potassium Channels, Inwardly Rectifying; D051381:Rats; D017207:Rats, Sprague-Dawley; D011955:Receptors, Drug / Q000378:metabolism*; D064233:Sulfonylurea Receptors; D014044:Tolbutamide / Q000494:pharmacology
chemical_list: D018528:ATP-Binding Cassette Transporters; D008024:Ligands; D026902:Potassium Channel Blockers; D015221:Potassium Channels; D024661:Potassium Channels, Inwardly Rectifying; D011955:Receptors, Drug; D064233:Sulfonylurea Receptors; D009320:Atrial Natriuretic Factor; D000255:Adenosine Triphosphate; D014044:Tolbutamide; D003847:Deoxyglucose; D003981:Diazoxide